Risk Adjusted Net Present Value: What is the current valuation of Iovance Biotherapeutics’s Lifileucel

Lifileucel (LN-145) i

Expansive new study points to distinct brain networks linked to sex and gender

Our brains are shaped by our experiences — whether you’re a bird watcher, book lover, or a chess player. And a new study offers a

July 13, 2024

New effort minimizes surgeon-specific standardized infection ratio

When excess surgical site infections (SSIs) were detected among neurosurgery patients at University of Pittsburgh Medical Center (UPMC) Mercy in 2019, infection preventionist Katie Palladino,

June 26, 2023

Verily lays out ‘Chapter 3’, streamlining its business under a new CEO and focusing on commercial side: #HLTH23

For Verily, it’s been a year of connecting the dots. The eight-year-old company got its start as Alphabet’s life sciences arm and, over the years,

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.